cordoncordon
Master Don Juan
- Joined
- Jun 2, 2006
- Messages
- 2,893
- Reaction score
- 110
I have a new bio type stock that I believe will move for a number of different reasons in the very near term...VRAL at .053. As many of you are aware, my two previous plays were medical plays that did very well. MMRF doubled at one point just about and is moving higher, and TELK has gone from .82 to $1.50 in just a week, and I feel VRAL will at least do a double to triple, and quite possibly much more. Again it's another play that is at a chart position that shows it is ready to move, and unlike many other guys that bring you stocks already way up, this one has not begun to move up yet...at all. It's been consolidating in the .055 range and imo is ready.
What I am hearing with VRAL is basically this:
1. A massive stealth promo, similar to the one that just ran TELK, is rumored to be starting. These are promos that fly under the radar and involve BUYING, not selling of stock. They arent used to dilute, as the people involved buy on the open market and trade with that. This type of promo will be used simply to take the stock higher, ala TELK the past week-even though you have heard nothing about it Smiley. (unless you were paying attention lol)
2. There is the "potential" for some massive, and I do mean massive news coming. Think of a bio play and what kind of news would move it. Usually that involves FDA approval of some sort. It has been rumored here for a while and finally getting it would be giant. This news alone will head it straight towards 25 cents imo.
3. A very nice write up in a prestigious bio tech magazine was recently put out, and I am hearing more are coming. They also just added one Noble Prize winner to the BOD and that is just the beginning of the coming additions.
The Biotech Stock Review recently issued a new Report on VRAL, on the heels of an announcement that Professor Montgainer who won the Noble Prize for Medicine, has joined VRAL's Advisory Board.
While it is not unusual or uncommon to see a Nobel prize winner join the Board of a billion dollar Biotech Company or a Multi-National Pharmaceutical giant -- how often, if ever have you seen that happen to a start-up Biotech Company -- which is selling for under 10 cents?
Now add to this the fact that Marshall Phelps, the IP attorney (Intellectual Property & Strategy) for MSFT has also joined the Company's Business Advisory Board it makes you wonder...what...along with the team of Harvard researchers, have they been working so feverishly on ?
Also, look at the chart. Not only is the MACD about to turn positive, but a GOLDEN CROSS is not far off as well-which is HUGE. IMO this is about to make a major breakout that should at least take it to .15 in the very near term. I hope Smiley.
What I am hearing with VRAL is basically this:
1. A massive stealth promo, similar to the one that just ran TELK, is rumored to be starting. These are promos that fly under the radar and involve BUYING, not selling of stock. They arent used to dilute, as the people involved buy on the open market and trade with that. This type of promo will be used simply to take the stock higher, ala TELK the past week-even though you have heard nothing about it Smiley. (unless you were paying attention lol)
2. There is the "potential" for some massive, and I do mean massive news coming. Think of a bio play and what kind of news would move it. Usually that involves FDA approval of some sort. It has been rumored here for a while and finally getting it would be giant. This news alone will head it straight towards 25 cents imo.
3. A very nice write up in a prestigious bio tech magazine was recently put out, and I am hearing more are coming. They also just added one Noble Prize winner to the BOD and that is just the beginning of the coming additions.
The Biotech Stock Review recently issued a new Report on VRAL, on the heels of an announcement that Professor Montgainer who won the Noble Prize for Medicine, has joined VRAL's Advisory Board.
While it is not unusual or uncommon to see a Nobel prize winner join the Board of a billion dollar Biotech Company or a Multi-National Pharmaceutical giant -- how often, if ever have you seen that happen to a start-up Biotech Company -- which is selling for under 10 cents?
Now add to this the fact that Marshall Phelps, the IP attorney (Intellectual Property & Strategy) for MSFT has also joined the Company's Business Advisory Board it makes you wonder...what...along with the team of Harvard researchers, have they been working so feverishly on ?
Also, look at the chart. Not only is the MACD about to turn positive, but a GOLDEN CROSS is not far off as well-which is HUGE. IMO this is about to make a major breakout that should at least take it to .15 in the very near term. I hope Smiley.